44,000 Shares in Acadia Healthcare Company, Inc. $ACHC Purchased by Josh Arnold Investment Consultant LLC

Key Points

• Josh Arnold Investment Consultant LLC has made a new investment of approximately $1.33 million in Acadia Healthcare Company, acquiring 44,000 shares, which now represents 1.1% of their portfolio.
• Acadia Healthcare recently reported $0.83 earnings per share for the last quarter, exceeding expectations and reflecting a 9.2% revenue increase compared to the previous year.
• Several analysts have revised their price targets for Acadia Healthcare, with the average target now set at $40.77, indicating a "Moderate Buy" consensus among analysts.

Josh Arnold Investment Consultant LLC acquired a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 44,000 shares of the company's stock, valued at approximately $1,334,000. Acadia Healthcare comprises 1.1% of Josh Arnold Investment Consultant LLC's holdings, making the stock its 10th largest position.

Other large investors have also made changes to their positions in the company. UMB Bank n.a. raised its position in Acadia Healthcare by 149.5% in the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after purchasing an additional 755 shares in the last quarter. Caitong International Asset Management Co. Ltd grew its stake in Acadia Healthcare by 11,218.2% during the first quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock worth $38,000 after buying an additional 1,234 shares during the last quarter. State of Wyoming bought a new stake in shares of Acadia Healthcare during the fourth quarter valued at approximately $56,000. Covestor Ltd grew its stake in shares of Acadia Healthcare by 56.0% during the first quarter. Covestor Ltd now owns 2,262 shares of the company's stock valued at $69,000 after purchasing an additional 812 shares during the last quarter. Finally, Twin Tree Management LP grew its stake in shares of Acadia Healthcare by 185.8% during the first quarter. Twin Tree Management LP now owns 5,691 shares of the company's stock valued at $173,000 after purchasing an additional 3,700 shares during the last quarter.

Analysts Set New Price Targets

Several analysts have recently commented on the stock. Royal Bank Of Canada decreased their price target on shares of Acadia Healthcare from $43.00 to $28.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 13th. Barclays reduced their price objective on shares of Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating on the stock in a research note on Thursday, August 7th. Wall Street Zen raised shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Sunday, August 3rd. KeyCorp reduced their price objective on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Finally, UBS Group reduced their price objective on shares of Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating on the stock in a research note on Thursday, August 7th. Eight analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $39.00.

Acadia Healthcare Trading Down 7.5%

ACHC traded down $1.75 during mid-day trading on Wednesday, hitting $21.55. The stock had a trading volume of 1,803,154 shares, compared to its average volume of 2,219,257. Acadia Healthcare Company, Inc. has a 1-year low of $17.13 and a 1-year high of $79.82. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32. The stock's fifty day simple moving average is $22.20 and its 200-day simple moving average is $24.58. The firm has a market capitalization of $1.99 billion, a price-to-earnings ratio of 14.37, a price-to-earnings-growth ratio of 4.43 and a beta of 0.89.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, topping analysts' consensus estimates of $0.71 by $0.12. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The business had revenue of $869.23 million for the quarter, compared to analyst estimates of $839.59 million. During the same period last year, the business posted $0.91 earnings per share. The firm's quarterly revenue was up 9.2% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. As a group, research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.